Topic: Pfizer Inc.

Pfizer depression drug ineffective, may be harmful: study

LONDON (Reuters) - Pfizer's antidepressant reboxetine is an "ineffective and potentially harmful" drug and published data on it overestimates the benefits and underplays the risks, a study by German researchers said on Wednesday.In a review published in the British Medical Journal, researchers ...

ANTIDEPRESSANT RISKS

When a Maryland psychiatrist suggested to Mathy Downing that her 12-year-old daughter take the antidepressant Zoloft in 2003, Downing had every reason to trust the advice. Her daughter, Candace, suffered extreme anxiety when she took tests at school. Eleven months later, Candace ...